These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29520623)

  • 1. Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [
    Sun Y; Zhao N; Liu W; Liu M; Ju Z; Li J; Cheng Z; Liu X
    Mol Imaging Biol; 2018 Oct; 20(5):771-779. PubMed ID: 29520623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [
    Li J; Chen P; Bao Y; Sun Y; He J; Liu X
    Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deuterated
    Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
    Xu Y; Tang J; Liu C; Zhao C; Cao S; Yu H; Chen Z; Xie M
    Nucl Med Biol; 2021; 96-97():9-18. PubMed ID: 33647803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [
    Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [
    Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE
    Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of
    Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW
    Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myopia induced by flickering light in guinea pig eyes is associated with increased rather than decreased dopamine release.
    Luo X; Li B; Li T; Di Y; Zheng C; Ji S; Ma Y; Zhu J; Chen X; Zhou X
    Mol Vis; 2017; 23():666-679. PubMed ID: 28966549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.
    Harris PE; Farwell MD; Ichise M
    Nucl Med Biol; 2013 Jan; 40(1):60-4. PubMed ID: 23102539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molar activity of [
    Liu C; Tang J; Xu Y; Cao S; Fang Y; Zhao C; Chen Z
    J Pharm Biomed Anal; 2021 Sep; 203():114212. PubMed ID: 34153939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
    Lin KJ; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Hsiao IT
    PLoS One; 2013; 8(9):e75952. PubMed ID: 24098749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
    Kilbourn MR; Hockley B; Lee L; Hou C; Goswami R; Ponde DE; Kung MP; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):233-7. PubMed ID: 17383572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain.
    Chen Z; Tang J; Liu C; Li X; Huang H; Xu X; Yu H
    Nucl Med Biol; 2016 Jan; 43(1):124-129. PubMed ID: 26526872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
    Zheng P; Lieberman BP; Choi SR; Plöessl K; Kung HF
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3435-8. PubMed ID: 21531556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
    PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VMAT2 imaging agent, D6-[
    Zhao R; Zha Z; Yao X; Ploessl K; Choi SR; Liu F; Zhu L; Kung HF
    Nucl Med Biol; 2019; 72-73():26-35. PubMed ID: 31330409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs.
    Dong F; Zhi Z; Pan M; Xie R; Qin X; Lu R; Mao X; Chen JF; Willcox MD; Qu J; Zhou X
    Mol Vis; 2011; 17():2824-34. PubMed ID: 22128230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.